HORGAN KEVIN 4
4 · SOLIGENIX, INC. · Filed Feb 2, 2011
Insider Transaction Report
Form 4
SOLIGENIX, INC.SNGX
HORGAN KEVIN
Senior VP; Chief Med Officer
Transactions
- Award
Stock Option (Right to Buy)
2011-01-31+1,250,000→ 1,250,000 totalExercise: $0.17From: 2011-01-31Exp: 2021-01-30→ Common Stock (1,250,000 underlying)
Footnotes (1)
- [F1]The option vests immediately as to 312,500 shares and vests as to the remainder of the shares on each three (3) month anniversary of the grant date at a rate of 78,125 shares per quarter. The exercise price of the option equals $0.172 per share, the market price of the Company's common stock as of the close of business on January 28, 2011.